Search filters

List of works by Sabine Cerny-Reiterer

5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand

scientific article

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection

scientific article published on 27 March 2014

A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL

scientific article (publication date: 2013)

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis

scientific article published on 24 December 2010

Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils

scientific article

CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

scientific article published on 11 October 2011

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

scientific article published on 11 September 2014

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy

scientific article published on March 2014

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia

scientific article

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

scientific article published on 28 April 2014

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

scientific article published on 14 October 2016

Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.

scientific article

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H

scientific article published on 26 November 2013

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

scientific article published on 8 May 2017

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

scientific article published on 25 November 2015

Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression

scientific article published on July 2012

Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms

scientific article

Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs

scientific article published on 22 October 2009

Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single 'hit' and cooperate in producing a mastocytosis-like disease in mice

scientific article

KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

scientific article published on 16 June 2011

Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.

scientific article

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases

scientific article published on 10 February 2016

Overexpression of primary microRNA 221/222 in acute myeloid leukemia

scientific article

Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field

scientific article

Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells

scientific article published on 12 August 2010

Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

scientific article

Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.

scientific article published on 17 January 2011

Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors

scientific article

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia

scientific article

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.

scientific article published on December 2012

Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS) ⬇️

scientific article published on November 1, 2010

Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation

scientific article

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis

scientific article

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

scientific article published on 19 September 2013

Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

scientific article published on 14 September 2015

Paulina is supported by:

About Paulina

Help